Exploring the Concept of Synthetic Lethality to Improve Therapeutic Options for Patients with Breast Cancer Conleth G. MurphyMaura N. Dickler Clinical Trial Report 21 February 2010 Pages: 1 - 3
Antiangiogenesis Therapy in Breast Cancer Arvinder BhinderSarah CarothersBhuvaneswari Ramaswamy ReviewPaper 23 February 2010 Pages: 4 - 15
Adjuvant Chemotherapy for Early Stage Breast Cancer: Current Trends and Future Directions Serena T. WongDeborah Toppmeyer ReviewPaper 25 February 2010 Pages: 16 - 24
Bone Disease in Breast Cancer: The Era of New Targeted Therapies Larissa A. KordeJulie R. Gralow ReviewPaper 17 March 2010 Pages: 25 - 31
Pharmacogenomics of Tamoxifen: Ready for Prime Time? Aditya BardiaVered Stearns ReviewPaper 25 February 2010 Pages: 32 - 41
Treatment of Her2-Positive Breast Cancer: What’s on the Horizon Windy Dean-ColombFrancisco J. Esteva ReviewPaper 09 March 2010 Pages: 42 - 52
Lymphedema: How Do We Diagnose and Reduce the Risk of This Dreaded Complication of Breast Cancer Treatment? Michael J. BernasRobert L. AskewJanice N. Cormier ReviewPaper 28 March 2010 Pages: 53 - 58